Consanguinity and Genetic Risk in Pregnancy

Consanguineous partners share a common ancestor, meaning they have a higher probability of sharing the same genetic variations (mutations). We all carry 'silent' genetic mutations (known as recessive mutations) that do not affect our health because we have two copies of every gene—one from each parent.

If only one parent has the mutation, the child will be a healthy carrier. However, if both parents carry the exact same recessive mutation, there is a 25% (1 in 4) chance with each pregnancy that the child will inherit two copies of the mutated gene and develop a genetic disorder. Because cousin couples share ancestors, they are more likely to carry the *same* recessive mutations.

In the general population, the baseline risk of a child being born with a significant congenital birth defect or genetic condition is about 2% to 3%.

For first-cousin couples, the additional risk is small—about 1.7% to 2.8% above the baseline (resulting in a total risk of approximately 4.7% to 5.8%). The risk increases slightly if there is a known family history of a specific genetic condition, or if consanguinity has been practiced over multiple generations.

The modern diagnostic pathway for consanguineous couples is highly precise and reassuring:

1. Pre-Pregnancy or Early Pregnancy Expanded Carrier Screening (ECS): This is a simple blood or saliva test for both partners. It screens for hundreds of autosomal recessive conditions. If both partners are found to be carriers of the *same* condition, they are at risk.
2. First Trimester Screening & Detailed Ultrasound: An expert MFM scan at 11-14 weeks to evaluate fetal anatomy and markers.
3. Invasive Prenatal Testing (Amniocentesis or CVS): If a shared genetic risk is identified, a sample of amniotic fluid or placenta can be tested via Chromosomal Microarray (CMA) or targeted gene testing to determine if the fetus has inherited the condition.

Management depends on the results of the carrier screening and diagnostic scans:

• Low Risk: If carrier screening shows no shared genetic mutations, the pregnancy is managed with standard high-quality MFM surveillance (first-trimester screening, second-trimester anomaly scan).
• High Genetic Risk: If a high-risk mutation is identified in both parents before pregnancy, Pre-implantation Genetic Testing (PGT) via IVF is an option, allowing selection of embryos unaffected by the condition. During pregnancy, early diagnosis via CVS or Amniocentesis provides clarity and allows for specialized birth planning.

The prognosis depends entirely on the specific genetic condition identified. Many autosomal recessive conditions can be managed effectively if diagnosed early (sometimes in-utero or immediately after birth). For couples with no shared mutations on expanded carrier screening, the risk of genetic disorders is comparable to that of non-consanguineous couples, providing immense peace of mind.

Couples who are second cousins or closer should ideally seek genetic counseling before planning a pregnancy, or as early in the pregnancy as possible.

Our Clinical Genetics specialist, Dr. Bernard, offers expert risk assessment, coordinates expanded carrier screening, and helps couples interpret complex genetic data to make informed choices for their family's health.